Search
for
Sort by
Research 30 of 1000+
- Drug-Induced Hair Loss and Hair Growth
- Drug-induced changes in hair growth
- Principles of management of women with hirsutism – a dermatologist’s perspective
- Medical treatment of hirsutism
- ABC of Dermatology: Diseases of the hair and scalp
- Dermatologic Clinics: Hair Disorders
- Drug Reactions Affecting Hair: Diagnosis
- SUN-118 A Case of Anastrozole Induced Hyperandrogenism
- Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth
- Drug eruptions in dermatology
- ALOPECIA AS A CONSEQUENCE OF TACROLIMUS THERAPY IN RENAL TRANSPLANTATION?
- Drug Repurposing in Dermatology: Molecular Biology and Omics Approach
- Long-term opioid ADR management in cancer patients
- A guide to diagnosis and management of hypertrichosis
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- INFLUENCE OF LIFESTYLE ON THE PROGNOSIS OF POLYCYSTIC OVARY SYNDROME
- Cutaneous Toxicities From Transplantation-Related Medications
- Drug-Induced Skin, Nail and Hair Disorders
- Drug-Induced Hair Disorders
- Drug-induced acne
- A Novel Effect of Acyclovir on Hair Growth in BALB/c Mice: A Promising Future for Finding a New Topical Drug for the Treatment of Hirsutism
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- Anticonvulsant-Induced Cutaneous Reactions
- Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone
- The Evaluation and Management of Hirsutism
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19